SToP Cancer SPORE: Career Enhancement Program

职业提升计划：摘要 UNC胰腺孢子职业提升计划(CEP)的主要目标是增加 将专注于胰腺癌研究的不同教职员工的职业发展。 这将通过以下方式实现：1)提供财政支持，以发展和加强这些机构的研究工作 2)为新进入该领域的研究人员提供临床和实验室指导。我们 意在促进从事胰腺癌研究的翻译研究人员的研究生涯。CEP将 从胰腺癌的整个翻译研究领域挑选研究人员提供支持；包括 公共卫生领域的预防和早期发现、诊断和其他相关领域的工作人员 人口科学；基础科学研究人员致力于将他们的发现转化为临床患者护理和 致力于改善胰腺癌患者预后的转化/临床研究人员。我们会 支持刚刚接触胰腺癌领域的高素质研究人员，重点关注早期职业生涯 或者职业生涯中期的调查人员过渡到这一领域工作。 CEP由The Lineberger负责翻译科学的副主任Jonathan Serody MD领导 综合癌症中心和伊丽莎白·托马斯医学、微生物学和免疫学教授。 共同领导人得到CEP咨询委员会(CEPAC)的支持，该委员会由共同领导人和 包括梅丽莎·特罗斯特，人口科学博士，安妮·门肯斯，博士(管理学)，安东尼奥·贝恩斯 博士(CEP少数民族顾问，NCCU)，阿尔伯特·鲍德温，博士(DRP主任)和Andrea Hayes-Jordan(儿科 手术)和我们的病人代言人。申请者将从高素质的调查人员库中挑选出来， 北卡罗来纳大学教堂山分校和北卡罗来纳中央大学历史悠久的黑人学院和 北卡罗来纳州达勒姆的一所大学与莱恩伯格综合癌症有很强的科学联系 该中心拥有大量非裔美国人和拉丁裔学生和博士后研究员。招聘 将强调对代表性不足的少数族裔、残疾人和妇女进行胰腺研究，并 将是贝恩斯博士在亚太委员会上努力的重点。 财政支持的初始期限为一年，如果有适当的资金支持，则可以续期 翻译进步。我们将与我们的伙伴机构合作，加强多机构 随着CEP的成熟，合作。

CAREER ENHANCEMENT PROGRAM: ABSTRACT The primary objective of the Career Enhancement Program (CEP) of the UNC Pancreas SPORE is to augment the career development of a diverse group of faculty members who will focus on pancreatic cancer research. This will be accomplished by 1) providing financial support to develop and enhance the research effort of these faculty and 2) to provide both clinical and laboratory mentoring for investigators who are new to the field. We intend to foster the research careers of translational investigators working in pancreatic cancer. The CEP will select investigators for support from the entire spectrum of translational research in pancreatic cancer; including those working in public health areas of prevention and early detection, diagnosis and other pertinent areas of population science; basic science investigators working to translate their findings to patient care in the clinic and translational/clinical investigators working to improve the outcome for patients with pancreatic cancer. We will support highly qualified investigators who are new to the field of pancreatic cancer with a focus on early career or mid-career investigators transitioning to work in this area. The CEP is led by Jonathan Serody MD Associate Director for Translational Science at the Lineberger Comprehensive Cancer Center and Elizabeth Thomas Professor of Medicine, Microbiology and Immunology. The co-leaders are supported by the CEP Advisory Committee (CEPAC) that is chaired by the co-leaders and includes Melissa Troester, PhD (Population Sciences), Anne Menkens, PhD (Administration), Antonio Baines PhD (CEP Minority Advisor, NCCU), Albert Baldwin, PhD (Director DRP), and Andrea Hayes-Jordan (Pediatric Surgery) and our patient advocates. Applicants will be selected from the highly qualified pool of investigators at the University of North Carolina Chapel Hill and North Carolina Central University an Historic Black College and University in Durham NC which has a strong scientific relationship with the Lineberger Comprehensive Cancer Center and has a large African American and Latino population of students and postdoctoral fellows. Recruitment of underrepresented minorities, disabled individuals, and women to pancreatic research will be emphasized and will be the focus of Dr. Baines’s efforts on the CEPAC. Financial support will be for an initial period of one year, that will be renewable if there has been appropriate translational progress. We will collaborate with our partner institutions to strengthen multi-institutional collaborations as the CEP matures.